Establishment Labs Holdings (ESTA) Reports In-Line Q4 EPS, Revenues Beat; Offers FY21 Revenue Guidance Above Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. META
2. TSLA
3. IBM
4. TXN
5. SAP
6. MRNA
7. CSX
8. QGEN
9. SPCX
10. WDC

Go back to Establishment Labs Holdings (ESTA) Reports In-Line Q4 EPS, Revenues Beat; Offers FY21 Revenue Guidance Above Consensus

Establishment Labs Reports Fourth Quarter and Full Year 2020 Financial Results; Record Fourth Quarter Revenue of $27.0 Million

March 10, 2021 8:00 AM EST

SANTA BARBARA, Calif.--(BUSINESS WIRE)-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on womens health, initially in the breast aesthetics and reconstruction market, today announced its financial results for the fourth quarter and full year ended December 31, 2020 and provided initial 2021 guidance.

Fourth Quarter Highlights and Outlook

Fourth quarter worldwide sales of $27.0 million, an increase of 11% year-over-year and a new quarterly record; consistent with preannouncement on January 11, 2021 2021 guidance of $110 million to $112 million, an increase of 30% to 32% over... More